Postes actifs de Thomas Burke
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Rovermed Biosciences LLC
 Rovermed Biosciences LLC BiotechnologyHealth Technology Rovermed Biosciences LLC develops precision targeted nanocapsule technology aimed at delivering life saving drugs to the most challenging disease sites. The company was founded in 2016 and is headquartered in St. Cloud, MN. | Directeur/Membre du Conseil | - | - |
| Président | - | - | |
Hennepin Life Sciences LLC
 Hennepin Life Sciences LLC Pharmaceuticals: MajorHealth Technology Hennepin Life Sciences LLC operates as a clinical-stage biotechnology company which focuses on identifying and developing antimicrobial therapeutics. It is advancing its novel antimicrobial, GML Gel, for local administration to prevent and treat CA-UTIs caused by ESKAPE pathogens in hospitals and long-term care centers. The company was founded by Patrick M. Schlievert, William Merrill Faulkner and Douglas Wicks in 2009 and is headquartered in Plymouth, MN. | Directeur/Membre du Conseil | - | - |
| Directeur Général | - | - |
Historique de carrière de Thomas Burke
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Director/Board Member | 2 |
| Chairman | 1 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Rovermed Biosciences LLC
Rovermed Biosciences LLC BiotechnologyHealth Technology Rovermed Biosciences LLC develops precision targeted nanocapsule technology aimed at delivering life saving drugs to the most challenging disease sites. The company was founded in 2016 and is headquartered in St. Cloud, MN. | Health Technology |
Hennepin Life Sciences LLC
Hennepin Life Sciences LLC Pharmaceuticals: MajorHealth Technology Hennepin Life Sciences LLC operates as a clinical-stage biotechnology company which focuses on identifying and developing antimicrobial therapeutics. It is advancing its novel antimicrobial, GML Gel, for local administration to prevent and treat CA-UTIs caused by ESKAPE pathogens in hospitals and long-term care centers. The company was founded by Patrick M. Schlievert, William Merrill Faulkner and Douglas Wicks in 2009 and is headquartered in Plymouth, MN. | Health Technology |
- Bourse
- Insiders
- Thomas Burke
- Expérience
